BACKGROUND The positive effects of growth hormone (GH) on IVF are often attributed to
improvements in oocyte and embryo quality. While emerging evidence emphasizes GH …

Administration of growth hormone (GH) during ovarian stimulation has shown beneficial
effects on in vitro fertilization (IVF) outcomes. It is generally believed that this improvement is …

Purpose Gonadotrophin releasing hormone agonist (GnRH-a) is widely used for pituitary
down-regulation and recruiting more follicles in assisted reproduction. However, no …

Growth hormone (GH) has been considered as an adjuvant treatment in human assisted
reproductive technology (ART) for several years. Its action was largely attributed to an …

Objective The efficacy of growth hormone (GH) co-treatment within a GnRH agonist long
regimen, in women with a normal ovarian response to controlled ovarian hyperstimulation …

Objective To evaluate the effects of gonadotropin-releasing hormone agonists (GnRH-a) on
fertility in women with mild endometriosis who are undergoing in vitro fertilization and …

Research question Does follicular stimulation using human menopausal gonadotrophin
(HMG) after pituitary down-regulation by a GnRH agonist improve endometrial thickness …

Background Growth hormone (GH) supplements have been shown to improve pregnancy
and live-birth rates, suggesting that GH has a beneficial effect on oocyte quality. However …

Objective To appraise the current randomized clinical trials (RCTs) for evidence of the
association of growth hormone (GH) with improved outcomes in infertile women with …

More than 3days' luteal endometrial advancement in IVF has been related with no
pregnancies. This study assessed the effect of recombinant and urinary human chorionic …